A phase Ib/II clinical trial on intratumoral autologous myeloid dendritic cell therapy in combination with AS01B adjuvant and immune-checkpoint blockade

Activiteit: Talk at a public lecture/debate

Periode19 mei 2022
EvenementstitelKnowledge For Growth
EvenementstypeConference
LocatieGent, Belgium
Mate van erkenningNational